Saskia Bolz
Eli Lilly (Germany)(DE)
Publications by Year
Research Areas
Neurogenetic and Muscular Disorders Research, Congenital Anomalies and Fetal Surgery, Myasthenia Gravis and Thymoma, Cancer Treatment and Pharmacology, Venous Thromboembolism Diagnosis and Management
Most-Cited Works
- → Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy(2018)87 cited
- → Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy(2020)50 cited
- → Neurofilament Heavy Chain and Tau Protein Are Not Elevated in Cerebrospinal Fluid of Adult Patients with Spinal Muscular Atrophy during Loading with Nusinersen(2019)49 cited
- → Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parameters(2021)43 cited
- → Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular Atrophy(2019)38 cited
- → Fatigue in adults with spinal muscular atrophy under treatment with nusinersen(2020)34 cited
- → Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study(2021)23 cited
- → Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy(2021)21 cited
- → Cognitive Impairment in Adult Patients with 5q-Associated Spinal Muscular Atrophy(2021)18 cited
- → Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?(2019)15 cited